HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rigas G Kalaitzidis Selected Research

Therapeutics

8/2013Renal sympathetic denervation and renal physiology.
1/2011The role of statins in chronic kidney disease.
2/2010Prehypertension: is it relevant for nephrologists?
11/2009The current state of RAAS blockade in the treatment of hypertension and proteinuria.
9/2009Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
3/2009Novel therapies of diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rigas G Kalaitzidis Research Topics

Disease

10Hypertension (High Blood Pressure)
01/2023 - 01/2008
6Albuminuria
01/2022 - 03/2009
5Chronic Renal Insufficiency
01/2022 - 01/2011
5Proteinuria
01/2017 - 03/2009
4Kidney Diseases (Kidney Disease)
01/2023 - 09/2009
3Obesity
01/2023 - 09/2011
3Atherosclerosis
10/2022 - 09/2010
3COVID-19
01/2022 - 12/2021
2Cardio-Renal Syndrome
08/2023 - 01/2023
2Overweight
01/2023 - 09/2011
2Chronic Kidney Failure (Chronic Renal Failure)
01/2023 - 01/2021
2Insulin Resistance
01/2023 - 01/2022
2Heart Failure
01/2022 - 01/2009
2Disease Progression
01/2022 - 01/2011
2Acute Kidney Injury (Acute Renal Failure)
01/2022 - 12/2021
2Stroke (Strokes)
05/2021 - 08/2017
1Anemia
08/2023
1Iron Deficiencies
08/2023
1Type 2 Diabetes Mellitus (MODY)
01/2023
1Prediabetic State (Prediabetes)
01/2023
1Weight Loss (Weight Reduction)
01/2023
1Non-alcoholic Fatty Liver Disease
12/2022
1Fibrosis (Cirrhosis)
11/2022
1Fatty Liver
11/2022
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
01/2022
1Vascular System Injuries
01/2022
1Hyperglycemia
01/2022
1Thromboembolism
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Lactic Acidosis
12/2021
1Myocardial Infarction
05/2021
1Hypertriglyceridemia
01/2021
1Dyslipidemias (Dyslipidemia)
01/2021
1Cognitive Dysfunction
01/2020
1IGA Glomerulonephritis (IGA Nephropathy)
08/2017
1Atrial Fibrillation
08/2017
1Hyperphosphatemia
01/2014
1Bone Diseases (Bone Disease)
01/2014
1Prehypertension
02/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2009

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2023 - 09/2010
4Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 09/2009
3CreatinineIBA
01/2022 - 09/2007
2SodiumIBA
01/2023 - 10/2022
2trimethyloxamine (trimethylamine N-oxide)IBA
12/2022 - 09/2007
2Indicators and Reagents (Reagents)IBA
11/2022 - 01/2022
2Glucose (Dextrose)FDA LinkGeneric
10/2022 - 01/2022
2SaltsIBA
01/2021 - 10/2016
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 01/2011
2ReninIBA
07/2015 - 01/2008
2AlbuminsIBA
07/2015 - 09/2009
2AngiotensinsIBA
07/2015 - 01/2008
2C-Reactive ProteinIBA
07/2015 - 01/2009
2aliskirenFDA Link
12/2014 - 03/2009
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
03/2009 - 01/2008
2Angiotensin Receptor AntagonistsIBA
03/2009 - 01/2008
1IronIBA
08/2023
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023
1HDL LipoproteinsIBA
01/2023
1Triglycerides (Triacylglycerol)IBA
01/2023
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
10/2022
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2022
1SymportersIBA
10/2022
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2022
1Antigen-Antibody Complex (Immune Complex)IBA
01/2022
1MelatoninIBA
01/2022
1Vitamin DFDA LinkGeneric
01/2022
1Metformin (Glucophage)FDA LinkGeneric
12/2021
1SmokeIBA
05/2021
1Lipoprotein(a)IBA
01/2021
1Proprotein Convertase 9IBA
01/2021
11,4-dihydropyridine (dihydropyridine)IBA
11/2018
1AnticoagulantsIBA
08/2017
1DabigatranFDA Link
08/2017
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2017
1Fibrinogen (Factor I)FDA Link
07/2015
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
07/2015
1Sevelamer (RenaGel)FDA Link
01/2014
1CalciumIBA
01/2014
1Phosphates (Orthophosphate)IBA
01/2014
1lanthanum carbonate (Fosrenol)FDA Link
01/2014
1LeptinIBA
09/2011
1alpha-2-HS-GlycoproteinIBA
09/2011
1AdiponectinIBA
09/2011
1Glycoproteins (Glycoprotein)IBA
03/2009
1Renin InhibitorsIBA
03/2009
1GlycosaminoglycansIBA
03/2009
1glucuronyl glucosamine glycan sulfate (sulodexide)IBA
03/2009
1LipidsIBA
01/2009
1ThiazolidinedionesIBA
01/2009

Therapy/Procedure

6Therapeutics
08/2013 - 03/2009
2Renal Dialysis (Hemodialysis)
01/2023 - 09/2011
2Renal Replacement Therapy (Therapies, Renal Replacement)
01/2022 - 01/2021
1Bariatric Surgery
10/2022
1Transjugular Intrahepatic Portasystemic Shunt
01/2017
1Sympathectomy (Sympathectomies)
08/2013
1Catheters
08/2013
1Secondary Prevention
01/2011
1Glycemic Control
09/2010
1Aftercare (After-Treatment)
11/2009